EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

Código QR

EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

Objective: To determine the efficacy of induction chemotherapy in locally advanced squamous cell carcinoma of head and neck. Study Design: Descriptive case series. Place and Duration of Study: This study was conducted at the Department of Oncology, Combined Military Hospital (CMH) Rawalpindi,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Muhammad Imran Khan Wajid, Usman Ali, Umair Aslam Shahzad Khan, Shahid Rasul, Ahsan Mahmood, Salman Arif
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2019
Materias:	squamous cell carcinoma induction chemotherapy Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/4e9162f73c7b4aabaf8d38a63e9abf41
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
por: Yang Li, et al.
Publicado: (2021)

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
por: Su Z, et al.
Publicado: (2020)

Prognostic Value of Preoperative Mean Platelet Volume and a Predictive Nomogram in Oral Squamous Cell Carcinoma Patients Based on Real-World Data
por: Ning Y, et al.
Publicado: (2021)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021)

Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma
por: Minami S, et al.
Publicado: (2016)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
por: Song C, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
por: Hongfu Cai, et al.
Publicado: (2021)

Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report
por: Shuluan Li, et al.
Publicado: (2021)

New Trend of Surgery in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
por: Tatcha Rerkrak, et al.
Publicado: (2021)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
por: Nighat Shahbaz, et al.
Publicado: (2020)

Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II–IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis
por: Jie Yang, et al.
Publicado: (2021)

Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia
por: Sarah Robinson, et al.
Publicado: (2020)

Neoplasia blástica de células dendríticas plasmocitoides: Caso clínico
por: Tapia E,Oscar, et al.
Publicado: (2012)

Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
por: Sarbani Ghosh-Laskar, et al.
Publicado: (2020)

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
por: Xinxin Zhu, et al.
Publicado: (2021)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zhen Zeng, et al.
Publicado: (2018)

A Comparative Study of Topicality and Writing Styles in Iranian and British Education Systems: The Cases of Deduction, Induction, and Quasi-induction
por: Mahmood Reza Moradian, et al.
Publicado: (2020)

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
por: Thomas M, et al.
Publicado: (2017)

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
por: Peng Yang, et al.
Publicado: (2021)

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
por: Lv SH, et al.
Publicado: (2021)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
por: Hassan CE, et al.
Publicado: (2016)

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
por: Cristina Porcheri, et al.
Publicado: (2021)

EFFICACY OF OLANZAPINE CONTAINING REGIMEN IN PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS OF BREAST CANCER RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY
por: Muhammad Umair, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Philipp Baumeister, et al.
Publicado: (2021)

IgG levels in Human Papillomavirus Infection Associated with Clinical Stage of Head and Neck Squamous Cell Carcinoma
por: Yussy Afriani Dewi, et al.
Publicado: (2021)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
por: Farzaneh Kordbacheh, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian X, et al.
Publicado: (2021)

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial
por: Mitsuro Kanda, et al.
Publicado: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Xing-xing Huo, et al.
Publicado: (2021)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu L, et al.
Publicado: (2021)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
por: Galo Méndez-Matías, et al.
Publicado: (2021)

Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy
por: Da-wei Zhao, et al.
Publicado: (2021)

REMISSION RATE OF PRE-B ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) AFTER INDUCTION CHEMOTHERAPY FOLLOWING UNITED KINGDOM ACUTE LYMPHOBLASTIC LEUKAEMIA 2011 (UKALL 2011) TRIAL PROTOCOL
por: Hafiz Muhammad Murtaza, et al.
Publicado: (2021)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Treewut Rassamegevanon, et al.
Publicado: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Xinwen Wang, et al.
Publicado: (2021)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
por: Lucrezia Togni, et al.
Publicado: (2021)

Acantholytic Squamous Cell Carcinoma
por: Sandy Maganito, et al.
Publicado: (2021)

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
por: Loredana G. Marcu, et al.
Publicado: (2021)

Chemotherapy research and practice